Anemia in hemoglobin E traits resistant to treatment: report of two cases
Main Article Content
Abstract
Introduction: The hemoglobin E traits are always asymptomatic; they mostly have normal hemoglobin concentration and normal MCV. Their hemoglobin analysis usually reveals only Hb A and E. But herein we reported two cases of supposed Hb E traits that had moderate microcytic anemia which could not be simply corrected. Case Presentation: Case 1. A 40-year-old Thai woman had moderate microcytic anemia without hepatosplenomegaly. Her blood tests showed: Hb 9.1 g%, MCV 52.3 fl, MCH 16.3 pg, ferritin 444.3 ng/ml, Hb analysis using the high performance liquid chromatography method: Hb AE, Hb E 15.2 %, Hb F 1.2 %. Case 2. A 36-year-old Thai woman had no anemic symptom and no hepatosplenomegaly. The blood tests included: Hb 9.3 g%, MCV 46.2fl, MCH 15.3 pg, ferritin 198 ng/ml, Hb analysis using the capillary zone electrophoresis method: Hb AE, Hb A 82.3 %, Hb E 12.0 %. They both were initially diagnosed as having Hb E heterozygosity with moderate anemia from unknown causes. They were supportively treated with the iron tablets and folic acid without the improvement within three months. Because both patients had some clues, viz. the Hb, MCV, MCH and the Hb E level which were all too low to be solely attributed by Hb E heterozygosity, the PCR for alpha thalassemia genes was performed and revealed the existence of Southeast Asian (SEA) and 3.7 kb deletions similarly in both patients. Their diagnoses were finally corrected to be Hb AEBart disease, the co-inheritance of Hb E heterozygosity and Hb H disease. Conclusion: The absence of Hb Bart in Hb AEBart disease could lead to the wrong diagnosis. To correct the diagnosis in this situation, it needs the clinical competence of the physician and the sophisticated test such as genotypes study.
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Vichinsky E. Hemoglobin E syndromes. Hematology Am Soc Hematol Educ Program 2007; 2007: 79-83.
Fucharoen S, Weatherall DJ. The hemoglobin E thalassemias. Cold Spring Harb Perspect Med 2012. doi: 10.1101/cshperspect.a011734.
Rahman MH, Yunus ABM, Begum M, Rahman MJ, Hoque MZ, Rahman M, et al. Coexisting iron deficiency anemia and thalassemia trait. http://www.orion-group. net/journals/Journals/ vol21_May2005/259.htm
Clarke GM, Higgins GN. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin Chem 2000; 46: 1284-90.
De Loughery TG. Microcytic anemia. N Engl J Med 2014; 371: 1324-31.
Johnson-Wimbley TD. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol 2011; 4: 177-84.
Chaibunruang A, Karnpean R, Fucharoen G, Fucharoen S. Genetic heterogeneity of hemoglobin AEBart's disease: a large cohort data from a single referral center in northeast Thailand. Blood Cells Mol Dis 2014; 52: 176-80. doi: 10.1016/j. bcmd.2013.11.006.
Pharephan S, Sirivatanapa P, Makonkawkeyoon S, Tuntiwechapikul W, Makonkawkeyoon L. Prevalence of á-thalassaemia genotypes in pregnant women in northern Thailand. Indian J Med Res 2016; 143: 315-22. doi: 10.4103/0971-5916.182622
Thonglairuam V, Winichagoon P, Fucharoen S, Wasi P. The molecular basis of AE-Bart's disease. Hemoglobin 1989; 13: 117-24.
Sanchaisuriya K, Fucharoen G, Sae-Ung N, Jetsrisuparb A, Fucharoen S. Molecular and hematologic features of hemoglobin E heterozygotes with different forms of alpha thalassemia in Thailand. Ann Hematol 2003; 82: 612-6.
Traivaree C, Boonyawat B, Monsereenusorn C, RujkijyanontP, Photia A. Clinical and molecular genetic features of Hb H and AE Bart’s diseases in central Thai children. Appl Clin Genet 2018; 11: 23-30.